Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.895 USD | +8.02% | +7.65% | +91.06% |
04-17 | RBC Raises Price Target on Nuvation Bio to $5 From $4, Keeps Outperform, Speculative Risk | MT |
04-10 | Nuvation Bio Closes Acquisition of AnHeart Therapeutics | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+91.06% | 704M | |
+1.41% | 42.75B | |
+47.70% | 41.61B | |
+11.70% | 41.34B | |
-8.83% | 26.59B | |
+6.41% | 25.49B | |
-23.41% | 18.12B | |
+29.92% | 12.24B | |
-2.58% | 11.76B | |
+8.17% | 11B |
- Stock Market
- Equities
- NUVB Stock
- News Nuvation Bio Inc.
- Wedbush Adjusts Price Target for Nuvation Bio to $5 From $17 on Discontinuation of NUV-422, Maintains Outperform Rating